GlassScriptPhysician profile
Danielle Lee Mallory
NPI 1003478686
$7,207.21
in general payments reported to CMS, 2019-2025
35 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,096 · 2022: $1,298 · 2023: $1,484 · 2024: $1,224 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,812.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,619.60 | 2021-2025 | |
| Glaxosmithkline, LLC. | $764.70 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $540.61 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $506.21 | 2021-2025 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $499.71 | 2024-2025 | Voquezna |
| Bausch Health US, LLC | $216.11 | 2021-2024 | Wellbutrin, Aplenzin |
| Astellas Pharma US INC | $204.03 | 2021-2025 | Myrbetriq, Veozah |
| Biohaven Pharmaceuticals, INC. | $193.67 | 2021 | |
| Lilly USA, LLC | $144.04 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Silk Road Medical, INC. | $132.39 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Pfizer INC. | $132.16 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $121.03 | 2023-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $105.83 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $102.02 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.91 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $89.05 | 2025 | Rexulti |
| Eisai INC. | $66.27 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.63 | 2025 | Trintellix |
| Exact Sciences Corporation | $58.91 | 2023-2024 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $58.02 | 2025 | Auvelity, Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.42 | 2022-2025 | Xifaxan, Trulance |
| Vanda Pharmaceuticals INC. | $54.62 | 2021-2025 | Fanapt |
| Sunovion Pharmaceuticals INC. | $53.13 | 2022 | |
| Scilex Pharmaceuticals INC. | $43.90 | 2021 | |
| Ironwood Pharmaceuticals, INC | $36.68 | 2023-2024 | Linzess |
| Merck Sharp & Dohme LLC | $36.50 | 2021 | |
| Allergan, INC. | $36.47 | 2021 | |
| Evoke Pharma, INC. | $32.22 | 2023-2025 | Gimoti |
| Neurocrine Biosciences, INC. | $25.91 | 2021 | |
| Endo Pharmaceuticals INC. | $24.60 | 2021 | |
| Urovant Sciences INC | $22.48 | 2022 | |
| Hologic Sales and Service, LLC | $22.32 | 2022 | |
| Watermark Medical, INC. | $19.60 | 2024 | |
| Alexion Pharmaceuticals, INC. | $15.81 | 2021 | |
| Amarin Pharma, INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mallory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.